Oncology trials often celebrate treatments improving progression-free survival, yet toxicity-related censoring can bias ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

Fecal microbiota transplantation has significantly improved progression-free survival in patients with metastatic renal cell ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

The company recorded a median progression-free survival duration of 5.3 months. All patients experienced treatment-emergent ...

The study added to a limited database about the effects of perioperative IO combinations, which have emerged as standard of ...

Source: Getty Images Avelumab plus axitinib was associated with signifi­cantly longer progression-free survival than ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...